Fate Therapeutics, Inc. (FATE)
1.28
-0.06
(-4.48%)
USD |
NASDAQ |
Nov 13, 16:00
1.275
0.00 (0.00%)
After-Hours: 19:59
Fate Therapeutics Price : 1.28 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 1.32 | 1.33 | 1.21 | 1.28 | 1.807M |
| Nov 12, 2026 | 1.58 | 1.585 | 1.250 | 1.34 | 3.688M |
| Nov 11, 2026 | 1.78 | 1.795 | 1.60 | 1.605 | 2.650M |
| Nov 10, 2026 | 1.90 | 1.959 | 1.70 | 1.77 | 1.766M |
| Nov 09, 2026 | 1.87 | 2.00 | 1.85 | 1.94 | 2.215M |
| Nov 06, 2026 | 1.85 | 1.95 | 1.81 | 1.835 | 1.862M |
| Nov 05, 2026 | 1.97 | 2.030 | 1.82 | 1.85 | 2.813M |
| Nov 04, 2026 | 2.05 | 2.10 | 2.025 | 2.09 | 723997.0 |
| Nov 03, 2026 | 2.02 | 2.12 | 2.005 | 2.04 | 876212.0 |
| Nov 02, 2026 | 2.09 | 2.15 | 1.98 | 2.01 | 1.267M |
| Oct 30, 2026 | 2.13 | 2.165 | 2.01 | 2.08 | 1.064M |
| Oct 29, 2026 | 2.17 | 2.23 | 2.12 | 2.17 | 804287.0 |
| Oct 28, 2026 | 2.04 | 2.18 | 2.035 | 2.17 | 1.106M |
| Oct 27, 2026 | 2.05 | 2.09 | 2.03 | 2.07 | 923557.0 |
| Oct 26, 2026 | 2.10 | 2.14 | 2.04 | 2.055 | 1.460M |
| Oct 23, 2026 | 2.08 | 2.135 | 2.015 | 2.11 | 1.111M |
| Oct 22, 2026 | 2.07 | 2.11 | 2.035 | 2.09 | 867181.0 |
| Oct 21, 2026 | 2.06 | 2.14 | 2.045 | 2.07 | 1.215M |
| Oct 20, 2026 | 1.86 | 2.145 | 1.84 | 2.06 | 1.772M |
| Oct 19, 2026 | 1.79 | 1.90 | 1.75 | 1.86 | 1.684M |
| Oct 16, 2026 | 1.94 | 1.975 | 1.78 | 1.79 | 1.384M |
| Oct 15, 2026 | 1.96 | 1.995 | 1.91 | 1.925 | 1.158M |
| Oct 14, 2026 | 1.95 | 1.99 | 1.89 | 1.94 | 1.674M |
| Oct 13, 2026 | 2.13 | 2.13 | 1.98 | 2.00 | 953482.0 |
| Oct 12, 2026 | 2.13 | 2.18 | 2.104 | 2.13 | 616846.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AVITA Medical, Inc. | 15.63 |
| Agenus, Inc. | 6.73 |
| Amgen, Inc. | 465.67 |
| Anika Therapeutics, Inc. | 13.40 |
| BioCryst Pharmaceuticals, Inc. | 7.61 |
Price Related Metrics
| PS Ratio | 32.56 |
| Price to Book Value | 1.169 |
| Earnings Yield | -80.48% |
| Market Cap | 155.56M |